Trial Profile

A Phase 1 Clinical Study of a Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 15 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs E 3112 (Primary)
Indications Liver disorders; Liver failure
Focus Pharmacokinetics
Sponsors EA Pharma

Most Recent Events

11 Mar 2021 Anticipated enrollment of patients decreased from 30 to 24 and number of study treatment arms reduced from 10 to 8.
11 Mar 2021 Status changed from recruiting to completed.
10 Dec 2019 Planned End Date changed from 1 Dec 2019 to 1 Jul 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com